GlobeNewswire - News from Pennsylvania http://www.yebxqs.cn/RssFeed/stateprovince/Pennsylvania/feedTitle/GlobeNewswire%20-%20News%20from%20Pennsylvania Contains the last 20 releases newsdesk@globenewswire.com (NewsDesk) Tue, 02 Mar 2021 14:00:00 GMT webmaster@globenewswire.com (Webmaster) http://www.yebxqs.cn/news-release/2021/03/02/2185426/0/en/Hamilton-Lane-Announces-Pricing-of-Public-Offering-of-Class-A-Common-Stock.html http://www.yebxqs.cn/news-release/2021/03/02/2185426/0/en/Hamilton-Lane-Announces-Pricing-of-Public-Offering-of-Class-A-Common-Stock.html Nasdaq:HLNE US4074971064 Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock BALA CYNWYD, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) (“Hamilton Lane”) today announced the pricing of an underwritten public offering by Hamilton Lane and certain selling stockholders of 1,453,110 shares of Class A common stock, in the aggregate, for gross proceeds of $128.2 million. The offering is expected to close on March 4, 2021, subject to customary closing conditions.

]]>
Tue, 02 Mar 2021 14:00 GMT 2185426 en GlobeNewswire Inc. Hamilton Lane Incorporated Tue, 02 Mar 2021 14:03 GMT Initial Public Offerings Stock Market News
http://www.yebxqs.cn/news-release/2021/03/02/2185366/0/en/Aspinity-Joins-STMicroelectronics-Partner-Program-to-Deliver-Complete-AnalogML-Solutions-for-Always-on-Edge-Processing.html http://www.yebxqs.cn/news-release/2021/03/02/2185366/0/en/Aspinity-Joins-STMicroelectronics-Partner-Program-to-Deliver-Complete-AnalogML-Solutions-for-Always-on-Edge-Processing.html Aspinity Joins STMicroelectronics Partner Program to Deliver Complete AnalogML Solutions for Always-on Edge Processing Analog machine learning pioneer aligns with leader in high-performance microcontrollers to support extended battery life in IoT devices]]> Tue, 02 Mar 2021 13:45 GMT 2185366 en GlobeNewswire Inc. Aspinity Tue, 02 Mar 2021 13:45 GMT Aspinity’s Voice-First Evaluation Kit includes ST’s STM32H743ZI MCU


]]>
GlobeNewswire Inc.
Partnerships Product / Services Announcement Aspinity always listening voice first voice-first STMicroelectronics ST analogML RAMP platform analog machine learning ST Partner
http://www.yebxqs.cn/news-release/2021/03/02/2185238/0/en/Arbutus-to-Participate-at-H-C-Wainwright-Global-Life-Sciences-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185238/0/en/Arbutus-to-Participate-at-H-C-Wainwright-Global-Life-Sciences-Conference.html Nasdaq:ABUS CA03879J1003 Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference WARMINSTER, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference held virtually from March 9-10, 2021.

]]>
Tue, 02 Mar 2021 13:00 GMT 2185238 en GlobeNewswire Inc. Arbutus Biopharma Corporation Tue, 02 Mar 2021 13:01 GMT Calendar of Events Arbutus Biopharma BIOTECHNOLOGY Conference WEBCAST
http://www.yebxqs.cn/news-release/2021/03/02/2185159/0/en/Neuronetics-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-and-Operating-Results.html http://www.yebxqs.cn/news-release/2021/03/02/2185159/0/en/Neuronetics-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-and-Operating-Results.html Nasdaq:STIM US64131A1051 Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2020.

]]>
Tue, 02 Mar 2021 12:30 GMT 2185159 en GlobeNewswire Inc. Neuronetics Tue, 02 Mar 2021 12:30 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/03/02/2185161/0/en/Strongbridge-Biopharma-plc-Announces-Submission-of-New-Drug-Application-for-RECORLEV-levoketoconazole-for-the-Treatment-of-Endogenous-Cushing-s-Syndrome-to-the-U-S-Food-Drug-Admini.html http://www.yebxqs.cn/news-release/2021/03/02/2185161/0/en/Strongbridge-Biopharma-plc-Announces-Submission-of-New-Drug-Application-for-RECORLEV-levoketoconazole-for-the-Treatment-of-Endogenous-Cushing-s-Syndrome-to-the-U-S-Food-Drug-Admini.html Nasdaq:SBBP IE00BYZ5XL97 Strongbridge Biopharma plc Announces Submission of New Drug Application for RECORLEV? (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome to the U.S. Food & Drug Administration ~ RECORLEV? (levoketoconazole) New Drug Application is Supported by Previously-Reported Positive and Statistically Significant Results from the Phase 3 SONICS and LOGICS Studies ~

]]>
Tue, 02 Mar 2021 12:30 GMT 2185161 en GlobeNewswire Inc. Strongbridge Biopharma plc Tue, 02 Mar 2021 12:30 GMT Product / Services Announcement
http://www.yebxqs.cn/news-release/2021/03/02/2185070/0/en/Baudax-Bio-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185070/0/en/Baudax-Bio-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html Nasdaq:BXRX US07160F1075 Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.

]]>
Tue, 02 Mar 2021 12:00 GMT 2185070 en GlobeNewswire Inc. Baudax Bio, Inc. Tue, 02 Mar 2021 12:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/02/2185071/0/en/Hamilton-Lane-Closes-Latest-Strategic-Opportunities-Fund-Series-on-Nearly-900M.html http://www.yebxqs.cn/news-release/2021/03/02/2185071/0/en/Hamilton-Lane-Closes-Latest-Strategic-Opportunities-Fund-Series-on-Nearly-900M.html Nasdaq:HLNE US4074971064 Hamilton Lane Closes Latest Strategic Opportunities Fund Series on Nearly $900M Sixth Series Designed to Target Private Credit Investments around the World]]> Tue, 02 Mar 2021 12:00 GMT 2185071 en GlobeNewswire Inc. Hamilton Lane Incorporated Tue, 02 Mar 2021 12:00 GMT Trading information http://www.yebxqs.cn/news-release/2021/03/02/2185101/0/en/Recro-to-Present-at-H-C-Wainwright-Global-Life-Science-Conference.html http://www.yebxqs.cn/news-release/2021/03/02/2185101/0/en/Recro-to-Present-at-H-C-Wainwright-Global-Life-Science-Conference.html Nasdaq:REPH US75629F1093 Recro to Present at H.C. Wainwright Global Life Science Conference MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright Global Life Science Conference. The conference, which will take place March 9-10, 2021, is being conducted with a virtual format.

]]>
Tue, 02 Mar 2021 12:00 GMT 2185101 en GlobeNewswire Inc. Recro Pharma, Inc. Tue, 02 Mar 2021 12:03 GMT Calendar of Events $reph Recro contract manufacturing manufacturing drug PHARMACEUTICALS CDMO
http://www.yebxqs.cn/news-release/2021/03/02/2185109/0/en/TELA-Bio-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-on-March-24-2021.html http://www.yebxqs.cn/news-release/2021/03/02/2185109/0/en/TELA-Bio-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-on-March-24-2021.html Nasdaq:TELA US8723811084 TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021 MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report fourth quarter and full year 2020 financial results on March 24, 2021. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.??

]]>
Tue, 02 Mar 2021 12:00 GMT 2185109 en GlobeNewswire Inc. Tela Bio Inc Tue, 02 Mar 2021 12:03 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/02/2185006/0/en/Micro-Measurements-New-Portable-Strain-Gage-Welding-Unit-Is-Capable-of-60-Welds-per-Minute-Making-it-One-of-the-Fastest-Tools-of-Its-Kind.html http://www.yebxqs.cn/news-release/2021/03/02/2185006/0/en/Micro-Measurements-New-Portable-Strain-Gage-Welding-Unit-Is-Capable-of-60-Welds-per-Minute-Making-it-One-of-the-Fastest-Tools-of-Its-Kind.html NYSE:VPG US92835K1034 Micro-Measurements’ New Portable Strain Gage Welding Unit Is Capable of 60 Welds per Minute Making it One of the Fastest Tools of Its Kind The Model 700B welder is lightweight and is powered by longer life rechargeable batteries]]> Tue, 02 Mar 2021 11:00 GMT 2185006 en GlobeNewswire Inc. Vishay Precision Group Tue, 02 Mar 2021 11:00 GMT 700B Welder_Fully assembled kit_IMG_0220-hpr


]]>
GlobeNewswire Inc.
Product / Services Announcement # Vishay Precision Group #Micro-measurements #weldable #straingages
http://www.yebxqs.cn/news-release/2021/03/02/2184819/0/en/Have-You-Lost-Money-Investing-In-Athenex-Inc-Securities-Kehoe-Law-Firm-P-C-Class-Action-Investigation-On-Behalf-Of-ATNX-Investors-Who-Have-Suffered-Losses-Greater-Than-50-000.html http://www.yebxqs.cn/news-release/2021/03/02/2184819/0/en/Have-You-Lost-Money-Investing-In-Athenex-Inc-Securities-Kehoe-Law-Firm-P-C-Class-Action-Investigation-On-Behalf-Of-ATNX-Investors-Who-Have-Suffered-Losses-Greater-Than-50-000.html Have You Lost Money Investing In Athenex, Inc. Securities? – Kehoe Law Firm, P.C. Class Action Investigation On Behalf Of ATNX Investors Who Have Suffered Losses Greater Than $50,000 PHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) to determine whether the Company engaged in securities fraud or other unlawful business practices.

]]>
Tue, 02 Mar 2021 01:29 GMT 2184819 en GlobeNewswire Inc. Kehoe Law Firm Tue, 02 Mar 2021 01:29 GMT Class Action Company Announcement Class Action
http://www.yebxqs.cn/news-release/2021/03/02/2184804/0/en/Kessler-Topaz-Meltzer-Check-LLP-Announces-a-Securities-Fraud-Class-Action-Filed-against-MultiPlan-Corporation-MPLN-MPLN-WS.html http://www.yebxqs.cn/news-release/2021/03/02/2184804/0/en/Kessler-Topaz-Meltzer-Check-LLP-Announces-a-Securities-Fraud-Class-Action-Filed-against-MultiPlan-Corporation-MPLN-MPLN-WS.html Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed against MultiPlan Corporation – MPLN; MPLN.WS RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against MultiPlan Corporation (NYSE: MPLN; MPLN.WS) (“MultiPlan”) f/k/a Churchill Capital Corp. III (“Churchill III”) on behalf of: (1) those who purchased or acquired MultiPlan securities between July 12, 2020 and November 10, 2020, inclusive (the “Class Period”); and (2) all holders of Churchill III Class A common stock entitled to vote on Churchill III’s merger with and acquisition of Polaris Parent Corp. and its consolidated subsidiaries consummated in October 2020 (the “Merger”).

]]>
Tue, 02 Mar 2021 00:11 GMT 2184804 en GlobeNewswire Inc. Kessler Topaz Meltzer & Check LLP Tue, 02 Mar 2021 00:11 GMT Class Action Law & Legal Issues securities securities class action securities fraud securities fraud class action shareholder investors class action lawsuit Class Action
http://www.yebxqs.cn/news-release/2021/03/01/2184796/0/en/INVESTOR-REMINDER-Kessler-Topaz-Meltzer-Check-LLP-Alerts-Shareholders-of-Securities-Class-Action-Lawsuit-Against-Bit-Digital-Inc-BTBT.html http://www.yebxqs.cn/news-release/2021/03/01/2184796/0/en/INVESTOR-REMINDER-Kessler-Topaz-Meltzer-Check-LLP-Alerts-Shareholders-of-Securities-Class-Action-Lawsuit-Against-Bit-Digital-Inc-BTBT.html INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Class Action Lawsuit Against Bit Digital, Inc. (BTBT) RADNOR, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Bit Digital, Inc. (NASDAQ: BTBT) (“Bit Digital”) on behalf of those who purchased or acquired Bit Digital securities between December 21, 2020 and January 8, 2021, inclusive (the “Class Period”).

]]>
Mon, 01 Mar 2021 23:41 GMT 2184796 en GlobeNewswire Inc. Kessler Topaz Meltzer & Check LLP Mon, 01 Mar 2021 23:41 GMT Class Action Law & Legal Issues securities securities fraud securities fraud class action securities class action shareholder investors class action lawsuit Class Action
http://www.yebxqs.cn/news-release/2021/03/01/2184771/0/en/STRATA-Skin-Sciences-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html http://www.yebxqs.cn/news-release/2021/03/01/2184771/0/en/STRATA-Skin-Sciences-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Nasdaq:SSKN US86272A2069 STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.?(NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that, as previously reported on its Form 8-K filed on March?1, 2021, effective as of the close of trading on March 1, 2021, the Company granted equity-based awards, in accordance with Nasdaq Listing Rule 5635(c)(4), to Robert Moccia as an inducement, material to Mr. Moccia entering into an employment agreement with the Company and commencing employment as its Chief Executive Officer and President. Mr. Moccia received an equity-based award of a stock option to purchase 1,632,590?shares of the Company’s common stock, with a strike price of $1.73 per share, vesting over a three year period, with 544,198 options vesting on the first anniversary of the date of grant and 136,049 options vesting every three months thereafter, provided in general that Mr. Moccia remains in the Company’s employ through each applicable vesting date and subject to the terms and conditions of the applicable award agreement.??

]]>
Mon, 01 Mar 2021 22:35 GMT 2184771 en GlobeNewswire Inc. STRATA Skin Sciences, Inc. Mon, 01 Mar 2021 22:35 GMT Health Stock Market News
http://www.yebxqs.cn/news-release/2021/03/01/2184755/0/en/Vertex-Announces-Fourth-Quarter-and-Full-Year-2020-Earnings-Release-and-Conference-Call-Date.html http://www.yebxqs.cn/news-release/2021/03/01/2184755/0/en/Vertex-Announces-Fourth-Quarter-and-Full-Year-2020-Earnings-Release-and-Conference-Call-Date.html Nasdaq:VERX US92538J1060 Vertex Announces Fourth Quarter and Full-Year 2020 Earnings Release and Conference Call Date KING OF PRUSSIA, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced it will release fourth quarter and full-year 2020 earnings before the market opens on March 10, 2021. A conference call to discuss its results will follow at 8:30 a.m. Eastern Time that same day.

]]>
Mon, 01 Mar 2021 22:00 GMT 2184755 en GlobeNewswire Inc. Vertex Inc. Mon, 01 Mar 2021 22:00 GMT Calendar of Events
http://www.yebxqs.cn/news-release/2021/03/01/2184743/0/en/Idera-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Provides-Corporate-Update.html http://www.yebxqs.cn/news-release/2021/03/01/2184743/0/en/Idera-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Provides-Corporate-Update.html Nasdaq:IDRA US45168K3068 Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update ILLUMINATE-301 Continues on Track for Data Later this Month]]> Mon, 01 Mar 2021 21:35 GMT 2184743 en GlobeNewswire Inc. Idera Pharmaceuticals, Inc. Mon, 01 Mar 2021 21:35 GMT Earnings Releases and Operating Results http://www.yebxqs.cn/news-release/2021/03/01/2184726/0/en/Hamilton-Lane-Announces-Public-Offering-of-Class-A-Common-Stock.html http://www.yebxqs.cn/news-release/2021/03/01/2184726/0/en/Hamilton-Lane-Announces-Public-Offering-of-Class-A-Common-Stock.html Nasdaq:HLNE US4074971064 Hamilton Lane Announces Public Offering of Class A Common Stock BALA CYNWYD, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) (“Hamilton Lane”) today announced that it has commenced an underwritten public offering of 1,453,110 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and certain selling stockholders, subject to market and other conditions.?

]]>
Mon, 01 Mar 2021 21:23 GMT 2184726 en GlobeNewswire Inc. Hamilton Lane Incorporated Mon, 01 Mar 2021 21:24 GMT Stock Market News
http://www.yebxqs.cn/news-release/2021/03/01/2184718/0/en/CrossAmerica-Partners-LP-Reports-Fourth-Quarter-and-Year-End-2020-Results.html http://www.yebxqs.cn/news-release/2021/03/01/2184718/0/en/CrossAmerica-Partners-LP-Reports-Fourth-Quarter-and-Year-End-2020-Results.html NYSE:CAPL US22758A1051 CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results Allentown, March 01, 2021 (GLOBE NEWSWIRE) --

CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results

]]>
Mon, 01 Mar 2021 21:15 GMT 2184718 en GlobeNewswire Inc. CrossAmerica Partners Mon, 01 Mar 2021 21:15 GMT Earnings Releases and Operating Results Company Announcement
http://www.yebxqs.cn/news-release/2021/03/01/2184719/0/en/OraSure-Technologies-Inc-Announces-2020-Full-Year-and-Fourth-Quarter-Financial-Results-and-Provides-COVID-19-Update.html http://www.yebxqs.cn/news-release/2021/03/01/2184719/0/en/OraSure-Technologies-Inc-Announces-2020-Full-Year-and-Fourth-Quarter-Financial-Results-and-Provides-COVID-19-Update.html Nasdaq:OSUR US68554V1089 OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update Full-Year 2020 Net Revenues of $172 Million Increased 11% Year-Over-Year, Driven by $50 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing

]]>
Mon, 01 Mar 2021 21:15 GMT 2184719 en GlobeNewswire Inc. OraSure Technologies, Inc. Mon, 01 Mar 2021 21:15 GMT Earnings Releases and Operating Results
http://www.yebxqs.cn/news-release/2021/03/01/2184720/0/en/Cohen-Company-Sets-Release-Date-for-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html http://www.yebxqs.cn/news-release/2021/03/01/2184720/0/en/Cohen-Company-Sets-Release-Date-for-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html NYSE:COHN US19248U1051 Cohen & Company Sets Release Date for Fourth Quarter and Full Year 2020 Financial Results PHILADELPHIA and NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) will release its financial results for the fourth quarter and full year 2020 on Wednesday, March 3, 2021. The Company will host a conference call at 11:00 a.m. Eastern Time (ET) that morning to discuss these results.

]]>
Mon, 01 Mar 2021 21:15 GMT 2184720 en GlobeNewswire Inc. Cohen & Company Inc. Mon, 01 Mar 2021 21:15 GMT Calendar of Events
粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号